| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9272575 | Revue du Rhumatisme | 2005 | 7 Pages |
Abstract
Conclusion. - We concluded that BT can be suggested as an effective symptomatic treatment modality in patients with AS. Furthermore, BT alone can obtain sufficient improvement in clinical parameters.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Merih M. Yurtkuran, Alev Ay, Yükel Karakoç,